Value Deepens for Medtech Stocks Hosted by MarketBeat StaffNovember 3, 2023 ShareLink copied to clipboard. Play video for Value Deepens for Medtech StocksDetailsGuestsResults from Johnson & Johnson and Abbott Laboratories foreshadow good news for MedTech investors. Both companies outperformed on the top and bottom lines, driven by broad strength in their MedTech units. Based on procedure volume data and the outlook for procedure growth, both companies should continue producing solid results over the next few years, which goes for the industry at large. Because the MedTech stocks are beaten up with a chance of outperforming consensus estimates, and many are trading at significant or critical support levels, a reversal looks imminent for the MedTech market.Stocks Mentioned in This EpisodeCompanyMarketRank™Current PriceDividend YieldP/E RatioJNJJohnson & Johnson4.9709 of 5 stars$151.87-0.9%3.27%21.98ABTAbbott Laboratories4.9871 of 5 stars$115.03-0.6%1.91%34.96ISRGIntuitive Surgical4.7325 of 5 stars$537.80+0.2%N/A86.46BAXBaxter International4.7943 of 5 stars$31.70-2.9%3.66%158.51MDTMedtronic4.9709 of 5 stars$86.00-2.2%3.26%29.05SYKStryker4.9465 of 5 stars$383.28-1.3%0.83%41.08 Compare These Stocks Add These Stocks to My Watchlist Chris Markoch, GuestMarketBeat Contributor, MarketBeatChris Markoch is a freelance financial copywriter with over five years of experience covering various aspects of the financial markets. You may find his writing a little different than other stock articles you’ve read. And that’s OK with him. Chris doesn’t have a traditional finance background. What he does bring to the table is a strong business and marketing background having worked for agencies that serviced Fortune 500 companies. With that in mind, he isn’t overly impressed with what companies say, and more focused on what they do. And because buyer behavior dictates so much of what happens with a stock, Chris always keeps the end consumer close in mind. Chris has been writing for MarketBeat since 2018.Thomas Hughes, GuestMarketBeat Contributor, MarketBeatThomas got his start with the markets while working as a Chef. In 2005 a chance invitation to attend the seminar “How To Buy And Sell Your Own Stocks” altered his worldview. Soon trading and stocks consumed his every waking moment to the point of excluding all else. Thomas now enjoys a much different lifestyle engaged in his true passion, uncovering great investments.Laycee Kluin, HostDigital Marketing Strategist, MarketBeatAs MarketBeat's Digital Marketing Strategist, Laycee helps with the marketing side of tasks including developing email campaigns, running the promotion of the MarketBeat products and exploring social media opportunities. She felt called to the Marketing industry because she enjoys collaborating with people and making connections. The University of Sioux Falls alum majored in Media Studies with minors in Communications and Spanish. Laycee brings a background in Financial Services Marketing.Previous VideoAll VideosNext Video Subscribe on YouTube Don't Miss a Video Subscribe to watch the latest stock market videos from MarketBeat. We empower investors to make better trading decisions by providing real-time financial data and objective market analysis. Subscribe on YouTube More From MarketBeatThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored7 of the Best Long-Term Stocks to BuyDespite the fact that Warren Buffett is one of its biggest proponents, buy-and-hold investing gets a bad rap a...MarketBeatMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredBetting on a Santa Claus Rally? Consider These 7 Risk-On StocksWe're getting into the time of year when people start talking about a Santa Claus rally. Specifically, that's ...MarketBeatMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves a company that pays strong dividends. Who doesn't like receiving a check every quarter f...MarketBeat ISRG Stock Surges: AI and Healthcare Innovation at the CoreWhy analysts are upgrading this stock, how it stands out from competitors, and whether it’s the right time to buy—or if you should wait for a pullback. Related VideosAnalysts Bullish on AI-Powered Healthcare: Intuitive Surgical’s 30% Upside Featured Articles and OffersDon't Miss a Second Chance to Buy These 2024 Winners for 2025November 20, 2024View Don't Miss a Second Chance to Buy These 2024 Winners for 2025Tesla Execs are Freaking OutFrom Angel Publishing(Ad)View Tesla Execs are Freaking OutTraders Are Flocking Back to Oil: What’s Fueling the OptimismNovember 19, 2024View Traders Are Flocking Back to Oil: What’s Fueling the OptimismIs Monolithic Power Systems a Screaming Buy After Near 40% Drop?November 18, 2024View Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?5 Dividend ETFs to Buy and Hold ForeverNovember 20, 2024View 5 Dividend ETFs to Buy and Hold ForeverTesla Execs are Freaking OutFrom Angel Publishing(Ad)View Tesla Execs are Freaking Out Search Headlines Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Hosted by MarketBeat StaffNovember 3, 2023 ShareLink copied to clipboard. Play video for Value Deepens for Medtech StocksDetailsGuestsResults from Johnson & Johnson and Abbott Laboratories foreshadow good news for MedTech investors. Both companies outperformed on the top and bottom lines, driven by broad strength in their MedTech units. Based on procedure volume data and the outlook for procedure growth, both companies should continue producing solid results over the next few years, which goes for the industry at large. Because the MedTech stocks are beaten up with a chance of outperforming consensus estimates, and many are trading at significant or critical support levels, a reversal looks imminent for the MedTech market.Stocks Mentioned in This EpisodeCompanyMarketRank™Current PriceDividend YieldP/E RatioJNJJohnson & Johnson4.9709 of 5 stars$151.87-0.9%3.27%21.98ABTAbbott Laboratories4.9871 of 5 stars$115.03-0.6%1.91%34.96ISRGIntuitive Surgical4.7325 of 5 stars$537.80+0.2%N/A86.46BAXBaxter International4.7943 of 5 stars$31.70-2.9%3.66%158.51MDTMedtronic4.9709 of 5 stars$86.00-2.2%3.26%29.05SYKStryker4.9465 of 5 stars$383.28-1.3%0.83%41.08 Compare These Stocks Add These Stocks to My Watchlist Chris Markoch, GuestMarketBeat Contributor, MarketBeatChris Markoch is a freelance financial copywriter with over five years of experience covering various aspects of the financial markets. You may find his writing a little different than other stock articles you’ve read. And that’s OK with him. Chris doesn’t have a traditional finance background. What he does bring to the table is a strong business and marketing background having worked for agencies that serviced Fortune 500 companies. With that in mind, he isn’t overly impressed with what companies say, and more focused on what they do. And because buyer behavior dictates so much of what happens with a stock, Chris always keeps the end consumer close in mind. Chris has been writing for MarketBeat since 2018.Thomas Hughes, GuestMarketBeat Contributor, MarketBeatThomas got his start with the markets while working as a Chef. In 2005 a chance invitation to attend the seminar “How To Buy And Sell Your Own Stocks” altered his worldview. Soon trading and stocks consumed his every waking moment to the point of excluding all else. Thomas now enjoys a much different lifestyle engaged in his true passion, uncovering great investments.Laycee Kluin, HostDigital Marketing Strategist, MarketBeatAs MarketBeat's Digital Marketing Strategist, Laycee helps with the marketing side of tasks including developing email campaigns, running the promotion of the MarketBeat products and exploring social media opportunities. She felt called to the Marketing industry because she enjoys collaborating with people and making connections. The University of Sioux Falls alum majored in Media Studies with minors in Communications and Spanish. Laycee brings a background in Financial Services Marketing.Previous VideoAll VideosNext Video Subscribe on YouTube Don't Miss a Video Subscribe to watch the latest stock market videos from MarketBeat. We empower investors to make better trading decisions by providing real-time financial data and objective market analysis. Subscribe on YouTube More From MarketBeatThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored7 of the Best Long-Term Stocks to BuyDespite the fact that Warren Buffett is one of its biggest proponents, buy-and-hold investing gets a bad rap a...MarketBeatMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredBetting on a Santa Claus Rally? Consider These 7 Risk-On StocksWe're getting into the time of year when people start talking about a Santa Claus rally. Specifically, that's ...MarketBeatMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves a company that pays strong dividends. Who doesn't like receiving a check every quarter f...MarketBeat
